Xlue Inc. cofounder Chenyan Xiong. The Carnegie Mellon University spinout company aims to identify patients at high risk for lung, liver and pancreatic cancer by using artificial intelligence.
Carnegie Mellon University/TNS
Lifestyles
February 17, 2026
Predicting cancer: This AI startup aims to upend cancer treatment
PITTSBURGH (TNS) — The best shot at curing cancer is catching it early, doctors say, but that does...


